Price alert —
Sign in to get a one-time email the moment ARDX crosses your price. Free accounts included.
Sign in / create a free accountPrice chart
Loading…
Latest bar · ARDX
Momentum reads · latest daily barGreen means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.
Financial overlay · last 12 quarters
The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.
| Quarter | Revenue | Net income | Op income | FCF | Net margin | Op margin |
|---|---|---|---|---|---|---|
| 2026-03-31 | $0.1B | $-0.0B | $-0.0B | $-0.0B | -39.8% | -34.7% |
| 2025-12-31 | $0.1B | $-0.0B | $0.0B | $0.0B | -0.3% | 4.1% |
| 2025-09-30 | $0.1B | $-0.0B | $0.0B | $0.0B | -0.9% | 4.2% |
| 2025-06-30 | $0.1B | $-0.0B | $-0.0B | $-0.0B | -19.5% | -14.7% |
| 2025-03-31 | $0.1B | $-0.0B | $-0.0B | $-0.0B | -55.5% | -49.0% |
Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.
Compare ARDX vs peers
Line ARDX up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.
Add tickers to compare with ARDX
~30 metrics across Snapshot, OdysseyHQ zone, Valuation, Growth, Quality, Technicals, Sentiment, and Risk — with a weighted score and a one-line read on each.
Earnings replay · last 20 reports
How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.
| Date | EPS actual | EPS est | Surprise | Next-day |
|---|---|---|---|---|
| 2026-04-30 | -0.15 | -0.14 | -5.0% | +8.7% |
| 2025-08-04 | -0.08 | -0.14 | +41.5% | +16.9% |
| 2025-05-01 | -0.17 | -0.07 | -126.7% | -24.5% |
| 2025-02-20 | 0.02 | — | +2802.7% | -11.5% |
| 2024-08-01 | -0.07 | -0.11 | +37.4% | +10.0% |
| 2024-05-02 | -0.11 | -0.16 | +32.3% | +28.4% |
| 2024-02-22 | -0.12 | -0.09 | -27.7% | -1.6% |
| 2023-10-31 | 0.03 | -0.11 | +127.7% | -0.2% |
| 2023-08-02 | -0.08 | -0.11 | +30.0% | -1.0% |
| 2023-05-03 | -0.13 | -0.10 | -34.8% | +0.4% |
| 2023-03-02 | 0.06 | — | +2486.2% | +32.2% |
| 2022-11-03 | -0.14 | -0.17 | +15.6% | +0.0% |
| 2022-08-04 | -0.19 | -0.20 | +6.0% | +4.0% |
| 2022-05-05 | -0.21 | -0.23 | +10.5% | -3.3% |
| 2022-02-28 | -0.31 | -0.34 | +8.2% | -5.5% |
| 2021-11-12 | -0.42 | -0.35 | -20.7% | +0.0% |
| 2021-08-13 | -0.45 | -0.37 | -22.4% | +4.2% |
| 2021-05-06 | -0.34 | -0.34 | +1.1% | — |
| 2021-03-08 | -0.32 | -0.27 | -19.5% | — |
| 2020-11-05 | -0.20 | -0.30 | +33.1% | — |
Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.
Peer comparison · Healthcare
Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.
| Ticker ⇅ | Mkt cap ⇅ | P/E ⇅ | Fwd P/E ⇅ | P/S ⇅ | EV/EBITDA ⇅ | P/B ⇅ | Gross M ⇅ | Rev gr ⇅ | EPS gr ⇅ | FCF yld ⇅ |
|---|---|---|---|---|---|---|---|---|---|---|
| ARDX ★ | $1B | — | 9.9 | 2.9 | -36.8 | 8.4 | 74.6% | 27.5% | — | 0.01% |
| LLY | $1,037B | 41.4 | 25.9 | — | 30.0 | 33.3 | 82.8% | 55.5% | 169.9% | 0.88% |
| UNH | $392B | 32.5 | 19.2 | 0.9 | 18.1 | 3.7 | 19.5% | 0.4% | 61.5% | 5.81% |
| JNJ | $615B | 29.7 | 19.9 | 6.3 | 18.3 | 7.6 | 68.1% | 6.6% | -1.0% | — |
| MRK | $315B | 35.9 | 13.2 | — | 12.0 | 6.9 | 76.7% | 4.9% | — | 4.46% |
| ABBV | $448B | 123.6 | 15.6 | 7.1 | 17.2 | -67.2 | 72.0% | 12.4% | -46.2% | 4.65% |
| PFE | $141B | 18.9 | 8.8 | — | 7.6 | 1.6 | 74.8% | 5.4% | -10.1% | 8.75% |
| TMO | $196B | 29.0 | 19.3 | — | 20.8 | 3.8 | 40.9% | 6.2% | 11.3% | 2.82% |
Auto-seeded from sector. Click any ticker to switch.
Ownership
Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.
Top institutional holders
Top-10 concentration: 41.18%
| Holder | Shares | % out |
|---|---|---|
| Blackrock Inc. | 21,164,132 | 8.57% |
| Millennium Management Llc | 17,842,370 | 7.22% |
| State Street Corporation | 13,604,307 | 5.51% |
| Vanguard Capital Management LLC | 10,365,512 | 4.20% |
| Janus Henderson Group PLC | 8,371,234 | 3.39% |
| Nomura Asset Management Internationa | 8,169,369 | 3.31% |
| Vanguard Portfolio Management LLC | 6,661,693 | 2.70% |
| Geode Capital Management, LLC | 6,007,455 | 2.43% |
| Nuveen, LLC | 5,234,683 | 2.12% |
| Two Sigma Investments, LP | 4,274,043 | 1.73% |
Insider activity · 90d
12 buys / 1 sells · ratio 12.0 · Finnhub
- Williams Laura A M 31,000
- Williams Laura A SELL 378,195 @ $5.99
- Williams Laura A M 460,093 @ $0.99
- Bhanji Muna BUY 39,715
- Bhanji Muna BUY 163,808
- Cadoret-Manier Onaiza BUY 39,715
- Cadoret-Manier Onaiza BUY 178,156
- Parsey Merdad BUY 39,715
- Parsey Merdad BUY 83,746
- Bazemore Robert B BUY 39,715
Analyst estimates
FinnhubWhat Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.
SEC filings
The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.
| Form | Filed | Description | Action |
|---|---|---|---|
| 4 | 2026-07-17 | FORM 4 | view · |
| 8-K | 2026-07-02 | 8-K | view · |
| 4 | 2026-06-22 | FORM 4 | view · |
| 4 | 2026-06-18 | FORM 4 | view · |
| 4 | 2026-06-18 | FORM 4 | view · |
| 4 | 2026-06-18 | FORM 4 | view · |
| 4 | 2026-06-18 | FORM 4 | view · |
| 4 | 2026-06-18 | FORM 4 | view · |
| 4 | 2026-06-18 | FORM 4 | view · |
| 4 | 2026-06-18 | FORM 4 | view · |
| 8-K | 2026-06-17 | 8-K | view · |
| 4 | 2026-06-17 | FORM 4 | view · |
| 4 | 2026-05-22 | FORM 4 | view · |
| 4 | 2026-05-22 | FORM 4 | view · |
| 4 | 2026-05-22 | FORM 4 | view · |
| 4 | 2026-05-22 | FORM 4 | view · |
| 4 | 2026-05-22 | FORM 4 | view · |
| 4 | 2026-05-22 | FORM 4 | view · |
| 4 | 2026-05-22 | FORM 4 | view · |
| 4 | 2026-05-22 | FORM 4 | view · |
| 4 | 2026-05-19 | FORM 4 | view · |
| 10-Q | 2026-04-30 | 10-Q | view · |
| 8-K | 2026-04-30 | 8-K | view · |
| DEF 14A | 2026-04-29 | DEF 14A | view · |
| 4 | 2026-04-17 | FORM 4 | view · |
| 4 | 2026-03-18 | FORM 4 | view · |
| 4 | 2026-02-25 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-23 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-23 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-23 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-23 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-23 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-23 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-23 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-23 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-23 | Insider transaction (Form 4) | view · |
| 10-K | 2026-02-19 | 10-K | view · |
| 8-K | 2026-02-19 | 8-K | view · |
| 4 | 2026-01-27 | Insider transaction (Form 4) | view · |
| 4 | 2026-01-26 | Insider transaction (Form 4) | view · |
| 4 | 2026-01-26 | Insider transaction (Form 4) | view · |
| 4 | 2026-01-26 | Insider transaction (Form 4) | view · |
| 4 | 2026-01-26 | Insider transaction (Form 4) | view · |
| 4 | 2026-01-26 | Insider transaction (Form 4) | view · |
| 4 | 2026-01-26 | Insider transaction (Form 4) | view · |
| 4 | 2026-01-26 | Insider transaction (Form 4) | view · |
| 4 | 2026-01-09 | FORM 4 | view · |
| 8-K | 2026-01-08 | 8-K | view · |
| 8-K | 2025-12-17 | 8-K | view · |
| 4 | 2025-11-25 | Insider transaction (Form 4) | view · |
| 4 | 2025-11-25 | Insider transaction (Form 4) | view · |
| 4 | 2025-11-25 | Insider transaction (Form 4) | view · |
| 4 | 2025-11-25 | Insider transaction (Form 4) | view · |
| 4 | 2025-11-25 | Insider transaction (Form 4) | view · |
| 4 | 2025-11-25 | Insider transaction (Form 4) | view · |
| 10-Q | 2025-10-30 | 10-Q | view · |
| 8-K | 2025-10-30 | 8-K | view · |
| 8-K | 2025-10-14 | 8-K | view · |
| 4 | 2025-08-28 | FORM 4 | view · |
| 4 | 2025-08-28 | FORM 4 | view · |
About ARDX
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. Ardelyx, Inc. was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. The company was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
Options picks · ARDX
ITM + OTM ideas from the latest scanLoading…
Congress trades · ARDX
STOCK Act disclosuresLoading…
SEC filings & insiders · ARDX
EDGAR · liveLoading…
Holders · ARDX
Institutions & insider activityLoading…